REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Embriovet Sas (Colombia)

Main Activities: Veterinary Services
Full name: Embriovet Sas Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Embriovet Sas is a company in Colombia, with a head office in Bogota D.C.. The company operates in the Veterinary Services industry. It was incorporated on November 15, 2012. 40 (2025) employees currently work for Embriovet Sas. There was a net sales revenue drop of 45.49% reported in Embriovet Sas’s latest financial highlights for 2024. Its’ total assets recorded a growth of 6.37%. In 2024, Embriovet Sas’s net profit margin increased by 2.74%.

Headquarters
Cra 65A # 94A - 88
Bogota D.C.; Bogota D.C; Postal Code: 0824

Contact Details: Purchase the Embriovet Sas report to view the information.

Basic Information
Total Employees:
Purchase the Embriovet Sas report to view the information.
Registered Capital:
Purchase the Embriovet Sas report to view the information.
Financial Auditors:
Purchase the Embriovet Sas report to view the information.
Incorporation Date:
November 15, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Embriovet Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-45.49%▼
Total operating revenue
-45.49%▼
Operating profit (EBIT)
-31.7%▼
EBITDA
-31.34%▼
Net Profit (Loss) for the Period
25.89%▲
Total Assets
6.37%▲
Total Equity
7.67%▲
Operating Profit Margin (ROS)
1.84%▲
Net Profit Margin
2.74%▲
Return on Equity (ROE)
1.03%▲
Debt/Equity
-0.81%▼
Quick Ratio
-0.71%▼
Cash Ratio
-1.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo